Skip to content

Cosmas Giallourakis

Chief Executive Officer at Pillar Therapeutics.

Earliest Form D on file: May 2026

Filed May 13, 2026

Pillar Therapeutics

Oligonucleotide medicines for hard-to-reach tissues

Biotech, Boston MA

Signed as Chief Executive Officer

$14M

sold of $25M offered

Form D

Network

At Pillar Therapeutics

4 people